Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 110.50
Bid: 109.50
Ask: 110.50
Change: 1.00 (0.91%)
Spread: 1.00 (0.913%)
Open: 110.00
High: 112.00
Low: 109.50
Prev. Close: 109.50
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

26 Jun 2019 07:00

RNS Number : 4151D
McBride PLC
26 June 2019
 

26 June 2019

 

McBride plc

 

Directorate change

 

McBride plc ("McBride" or the "Company") announces the appointment of Jeffrey Nodland as a Non-Executive Director with immediate effect.

 

Jeffrey has extensive experience in consumer chemicals manufacturing businesses including both private label and contract manufacturing activities. He was most recently President and CEO of KIK Custom Products, one of North America's largest independent manufacturers of consumer packaged goods, where between February 2008 and January 2019 he led the turnaround and growth of the business both organically and via acquisition.

 

Previously, Jeffrey held senior positions at speciality chemical businesses including Hexion Speciality Chemicals, Inc., McWhorter Technologies and The Valspar Corporation, with responsibility for activities at a number of speciality chemical plants in western and central Europe, including the UK, Belgium, Italy and Germany.

 

Jeffrey is currently an independent non-executive director of EcoSynthetix, a developer and manufacturer of bio-based polymers for the wood composite and paper industry, which is listed on the Toronto Stock Exchange, and a board member of Augsburg University, Minneapolis. He is a US citizen.

 

Jeffrey will become a member of the Nomination, Remuneration and Audit Committees.

 

John Coleman, Chairman of McBride, said: "We are delighted that Jeff has agreed to join us at McBride. His extensive experience in the household and personal care industry as well as private label and contract manufacturing will bring additional relevant experience to McBride and prove invaluable to the Board in our future discussions."

 

 

McBride has been notified that there are no further details to be disclosed in respect of Jeffrey Nodland pursuant to Rule 9.6.13 of the Listing Rules of the UK Listing Authority

 

 

McBride plc

 

John Coleman, Chairman

0161 203 7570

Rik De Vos, CEO

 

 

 

FTI Consulting

 

Ed Bridges, Nick Hasell

020 3727 1017

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEAFKSALANEAF
Date   Source Headline
1st Mar 20214:51 pmRNSTransaction in Own Shares
26th Feb 20215:03 pmRNSTransaction in Own Shares
25th Feb 20215:38 pmRNSDirector/PDMR Shareholding
25th Feb 20214:57 pmRNSTransaction in Own Shares
24th Feb 20214:56 pmRNSTransaction in Own Shares
23rd Feb 20214:53 pmRNSTransaction in Own Shares
23rd Feb 20217:01 amRNSCapital Markets Day
23rd Feb 20217:00 amRNSHalf-year Report
22nd Feb 20214:56 pmRNSTransaction in Own Shares
19th Feb 20214:59 pmRNSTransaction in Own Shares
18th Feb 20214:59 pmRNSTransaction in Own Shares
17th Feb 20214:54 pmRNSTransaction in Own Shares
16th Feb 20214:57 pmRNSTransaction in Own Shares
15th Feb 20214:52 pmRNSTransaction in Own Shares
12th Feb 20214:58 pmRNSTransaction in Own Shares
11th Feb 20214:50 pmRNSTransaction in Own Shares
10th Feb 20215:00 pmRNSTransaction in Own Shares
10th Feb 20217:00 amRNSNotice of Results and Capital Markets Day
9th Feb 20215:05 pmRNSTransaction in Own Shares
9th Feb 20218:53 amRNSAppointment of Joint Broker
8th Feb 20214:58 pmRNSTransaction in Own Shares
5th Feb 20214:56 pmRNSTransaction in Own Shares
4th Feb 20215:06 pmRNSTransaction in Own Shares
3rd Feb 20214:58 pmRNSTransaction in Own Shares
2nd Feb 20215:01 pmRNSTransaction in Own Shares
1st Feb 20215:01 pmRNSTransaction in Own Shares
29th Jan 20214:55 pmRNSTransaction in Own Shares
28th Jan 20214:56 pmRNSTransaction in Own Shares
27th Jan 20215:02 pmRNSTransaction in Own Shares
26th Jan 20215:03 pmRNSTransaction in Own Shares
25th Jan 20215:15 pmRNSTransaction in Own Shares
25th Jan 20219:06 amRNSTransaction in Own Shares
25th Jan 20219:05 amRNSTransaction in Own Shares
20th Jan 20215:17 pmRNSTransaction in Own Shares
19th Jan 20215:26 pmRNSTransaction in Own Shares
15th Jan 20214:59 pmRNSTransaction in Own Shares
14th Jan 20214:54 pmRNSTransaction in Own Shares
13th Jan 20215:00 pmRNSTransaction in Own Shares
12th Jan 20214:54 pmRNSTransaction in Own Shares
11th Jan 20214:58 pmRNSTransaction in Own Shares
8th Jan 20214:57 pmRNSTransaction in Own Shares
8th Jan 202111:32 amRNSDirector/PDMR Shareholding
8th Jan 202110:43 amRNSTransaction in Own Shares
7th Jan 20215:02 pmRNSTransaction in Own Shares
7th Jan 20214:52 pmRNSTransaction in Own Shares
7th Jan 20218:46 amRNSHolding(s) in Company
6th Jan 20215:16 pmRNSTransaction in Own Shares
6th Jan 20214:26 pmRNSHolding(s) in Company
5th Jan 20214:58 pmRNSTransaction in Own Shares
29th Dec 20205:19 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.